KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Current Deferred Revenue (2016 - 2023)

Historic Current Deferred Revenue for Biolife Solutions (BLFS) over the last 14 years, with Q1 2023 value amounting to $422000.0.

  • Biolife Solutions' Current Deferred Revenue fell 5284.92% to $422000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $422000.0, marking a year-over-year decrease of 5284.92%. This contributed to the annual value of $548000.0 for FY2022, which is 3267.81% down from last year.
  • According to the latest figures from Q1 2023, Biolife Solutions' Current Deferred Revenue is $422000.0, which was down 5284.92% from $548000.0 recorded in Q4 2022.
  • Biolife Solutions' Current Deferred Revenue's 5-year high stood at $944000.0 during Q2 2021, with a 5-year trough of $324000.0 in Q4 2019.
  • For the 5-year period, Biolife Solutions' Current Deferred Revenue averaged around $646363.6, with its median value being $662000.0 (2021).
  • Per our database at Business Quant, Biolife Solutions' Current Deferred Revenue surged by 18734.57% in 2020 and then plummeted by 5434.32% in 2022.
  • Over the past 5 years, Biolife Solutions' Current Deferred Revenue (Quarter) stood at $324000.0 in 2019, then surged by 187.35% to $931000.0 in 2020, then fell by 12.57% to $814000.0 in 2021, then plummeted by 32.68% to $548000.0 in 2022, then decreased by 22.99% to $422000.0 in 2023.
  • Its last three reported values are $422000.0 in Q1 2023, $548000.0 for Q4 2022, and $429000.0 during Q3 2022.